HOUSE BILL No. 4976

 

July 16, 2003, Introduced by Reps. Accavitti, Vagnozzi, Bieda, Paletko, Brandenburg, Tobocman, Dennis, Condino and Murphy and referred to the Committee on Health Policy.

        

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                

                                                                                 A bill to amend 1978 PA 368, entitled                                             

                                                                                

    "Public health code,"                                                       

                                                                                

    by amending section 17755 (MCL 333.17755).                                  

                                                                                

                THE PEOPLE OF THE STATE OF MICHIGAN ENACT:                      

                                                                                

1       Sec. 17755.  (1) When a pharmacist receives a prescription                  

                                                                                

2   for a brand name drug product  , the pharmacist may, or when a              

                                                                                

3   purchaser requests  and a lower cost generically equivalent drug            

                                                                                

4   product is available, the pharmacist shall dispense  a  the lower           

                                                                                

5   cost  but not higher cost  generically equivalent drug product,             

                                                                                

6   if available in the pharmacy,  except as provided in subsection            

                                                                                

7   (3).  If a drug is dispensed which is not the prescribed brand,             

                                                                                

8   the purchaser shall be notified and the prescription label shall            

                                                                                

9   indicate both the name of the brand prescribed and the name of              

                                                                                

10  the brand dispensed and designate each respectively.  If the                

                                                                                

11  dispensed drug does not have a brand name, the prescription label           

                                                                                


                                                                                

1   shall indicate the generic name of the drug dispensed, except as            

                                                                                

2   otherwise provided in section 17756.                                        

                                                                                

3       (2) If a pharmacist dispenses a generically equivalent drug                 

                                                                                

4   product, the pharmacist shall pass on the savings in cost to the            

                                                                                

5   purchaser or to the third party payment source if the                       

                                                                                

6   prescription purchase is covered by a third party pay contract.             

                                                                                

7   The savings in cost is the difference between the wholesale cost            

                                                                                

8   to the pharmacist of the 2 drug products.                                   

                                                                                

9       (3) The pharmacist shall not dispense a generically                         

                                                                                

10  equivalent drug product under subsection (1) if any of the                  

                                                                                

11  following applies:                                                          

                                                                                

12      (a) The prescriber, in the case of a prescription in writing                

                                                                                

13  signed by the prescriber, writes in his or her own handwriting              

                                                                                

14  "dispense as written" or "d.a.w."  on the prescription.                     

                                                                                

15      (b) The prescriber, having preprinted on his or her                         

                                                                                

16  prescription blanks the statement "another brand of a generically           

                                                                                

17  equivalent product, identical in dosage, form, and content of               

                                                                                

18  active ingredients, may be dispensed unless initialed d.a.w.",              

                                                                                

19  writes in his or her own handwriting, the initials "d.a.w."  in a           

                                                                                

20  space, box, or square adjacent to the statement.                            

                                                                                

21      (c) The prescriber, in the case of a prescription other than                

                                                                                

22  one in writing signed by the prescriber, expressly indicates the            

                                                                                

23  prescription is to be dispensed as communicated.                            

                                                                                

24      (4) A pharmacist may not dispense a drug product with a total               

                                                                                

25  charge that exceeds the total charge of the drug product                    

                                                                                

26  originally prescribed, unless agreed to by the purchaser.